Novo Nordisk at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
Novo Nordisk takes part in 2 sessions at FoG London 2027 in London. Its program centres on AI for drug discovery. One session covers teaching AI to understand biology from experiments that perturb cells, so it can help choose which drugs to pursue.
| Organization | FoG London 2027 Attendance |
|---|---|
Novo Nordisk Bagsværd, Denmark | |
Danish pharmaceutical company focused on diabetes, obesity and other serious chronic diseases. | Talk Thu Jan 28 12:30–13:00 Session (details to come) How biology-led AI could turn many kinds of data into evidence strong enough to choose and prioritise drug targets early in research. Talk Thu Jan 28 15:10–15:40 Teaching AI to Understand Biology: From Cellular Perturbations to Intelligent Drug Discovery Whether AI models, including large language models, can predict cell responses to drugs, reason about biology and run bioinformatics tasks reliably. |
Find decision makers at Novo Nordisk
Tell us what you sell and we’ll find the people at Novo Nordisk most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction